Skip to main content

Table 1 Results of univariate multiple logistic analysis of potential risk factors for failed CR among dogs treated with a combined MMF-prednisolone therapy

From: Evaluation of treatment with a combination of mycophenolate mofetil and prednisolone in dogs with meningoencephalomyelitis of unknown etiology: a retrospective study of 86 cases (2009–2017)

Factor

CR, % (n)

Failed CR, % (n)

P

Sex

 Male

66.67 (18)

33.33 (9)

0.789

 Female

66.1 (39)

33.9 (20)

 

Age

  < = 7 years

61.67 (37)

38.33 (23)

0.083

  > 7 years

76.92 (20)

23.08 (6)

 

Lesion distribution

 Focal

75.56 (34)

24.44 (11)

0.087

 Multifocal

56.1 (23)

43.9 (18)

 

Brainstem involvement

 Negative

73.33 (44)

26.67 (16)

0.179

 Positive

50 (13)

50 (13)

 

Seizure

 Negative

53.49 (23)

46.51 (20)

0.393

 Positive

79.07 (34)

20.93 (9)

 

Seizure as the only symptom

 Negative

55.77 (29)

44.23 (23)

0.013a

 Positive

82.35 (28)

17.65 (6)

 

Body weight

0.758

TNCC

0.162

Symptom duration before treatment

0.568

  1. aodds ratio, 3.701; 95% confidence interval, 1.311–10.488
  2. CR complete response, TNCC total nucleated cell count